학술논문

Phase i Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer

Document Type

Article

Author

Chiappori, A.A.; Creelan, B.; Tanvetyanon, T.; Gray, J.E.; Haura, E.B.; Beg, A.A.; Thapa, R.; Chen, Z.; Chen, D.T.; Barlow, M.L.; Boyle, T.A.; Castro, J.; Morgan, L.; Aregay, M.; Hurtado, F.K.; Morris, E.; Manenti, L.; Antonia, S.

Source

In: Clinical Cancer Research. (Clinical Cancer Research, 1 June 2022, 28(11):2313-2320)

Subject

Language

English

ISSN

15573265
10780432

Online Access

Full Text (ECC - 개별구독 전자저널) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송